Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the prostate health market grown in recent years?

The market size for prostate health has been on a consistent rise in recent years. It’s expected to escalate from $34.07 billion in 2024 to $37.34 billion in 2025, marking a compound annual growth rate (CAGR) of 9.6%. This growth during the historic period is backed by factors such as an increasing elderly population, heightened psa screenings, proliferating awareness campaigns, advanced hormone therapies, and escalating incidence rates.

How is the prostate health market size expected to evolve during the forecast period?

In the upcoming years, the prostate health market is predicted to witness significant growth, surging to $53.25 billion in 2029 with a CAGR of 9.3%. This growth during the forecast period could be credited to the increasing integration of precision medicine, the extensive use of diagnostics driven by AI, expansion in specific radiotherapies, a high demand for less invasive treatments, and advancements in genetic risk profiling. The key trends in the forecast period comprise risk assessments powered by AI, progressions in liquid biopsies, the evolution of next-generation radiotheranostics, breakthroughs in immunotherapy, and real-time monitoring of biomarkers.

Get your prostate health market report here!

https://www.thebusinessresearchcompany.com/report/prostate-health-global-market-report

Which key drivers are propelling the prostate health market’s growth?

The increased number of prostate cancer cases is predicted to stimulate the prostate health market’s expansion in the future. When the glandular cells of the prostate proliferate uncontrollably, it results in prostate cancer, frequently presenting as adenocarcinomas – the most prevalent form of the disease in males. The escalating incidence of prostate cancer is primarily driven by an aging population, enhanced screening methodologies, and lifestyle factors such as lack of physical activity and obesity. Maintaining prostate health is crucial for preventing, early diagnosing, and treating prostate cancer. To illustrate, the American Cancer Society (ACS), a non-profit organization based in the US, predicted in January 2023 that around 288,300 fresh cases of prostate cancer would be detected in the U.S. in 2023, with an anticipated 34,700 deaths from the disease. Consequently, the climbing incidence of prostate cancer will spur the growth of the prostate health market.

What are the market segments in the prostate health industry?

The prostate health market covered in this report is segmented –

1) By Disease Indication: Prostate Cancer, Benign Prostate Hyperplasia, Prostatitis

2) By Treatment: Hormonal Therapy, Chemotherapy, Surgical Treatments, Other Treatments

3) By Distribution Channel: E-Commerce Stores, Pharmacies, Other Distribution Channels

Subsegments:

1) By Prostate Cancer: Localized Prostate Cancer, Metastatic Prostate Cancer

2) By Benign Prostate Hyperplasia: Mild BPH, Moderate BPH, Severe BPH

3) By Prostatitis: Acute Bacterial Prostatitis, Chronic Bacterial Prostatitis, Chronic Prostatitis (Non-Bacterial)

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21265&type=smp

Which leading companies are shaping the growth of the prostate health market?

Major companies operating in the prostate health market are Pfizer Inc., Johnson & Johnson, Siemens Healthineers AG, Bayer AG, Sanofi SA, AstraZeneca PLC, Abbott Laboratories, Novartis AG, Takeda Pharmaceutical Co Ltd, Astellas Pharma Inc, Genentech Inc., Teleflex Inc., Elekta AB, Myriad Genetics Inc., Freenome, Theragenics Corporation, CureVac BV, ArsenalBio, Roivant Sciences, Artera Inc., Veru Inc., HistoSonics Inc., Immunic Inc., Ezra, Francis Medical, CorTechs Labs, Lucida Medical, Serimmune Inc., Alessa Therapeutics.

Which trends are expected to transform the prostate health market?

Hardware and software advancements, such as the use of artificial intelligence in risk assessment, are being prioritized by leading companies in the prostate health market in order to outdo their competitors. These AI-powered risk assessment tools leverage AI algorithms to study data and forecast potential hazards, thereby aiding smarter decision-making and yielding better results. An apt example of this would be the collaboration between Canadian clinical-stage biotechnology firm, Nanostics Inc., and Protean BioDiagnostics, an American biotechnology company, in September 2024. They came together to roll out CDX Prostate, a diagnostic tool created specifically for identifying men who are at risk of developing aggressive prostate cancer. CDX Prostate integrates biological data, clinical details and AI-fueled learning models to compute a risk score for aggressive onset of prostate cancer. Using sophisticated machine learning algorithms, CDX Prostate processes diverse biological and clinical data to provide a more comprehensive risk score for aggressive prostate cancer than standard methods. This test serves as an aid for healthcare providers and patients in deciding whether to go ahead with a biopsy following a high prostate-specific antigen (PSA) test result or an unusual digital rectal examination (DRE).

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21265

Which geographic areas are influencing the growth of the prostate health market?

North America was the largest region in the prostate health market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prostate health market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Type 1 Diabetes Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/type-1-diabetes-global-market-report

Type 2 Diabetes Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/type-2-diabetes-global-market-report

Digital Diabetes Management Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/digital-diabetes-management-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: